Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity (2022)
- Authors:
- USP affiliated authors: PEREIRA, VANESSA CARREGARO - FMRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidade: FMRP
- DOI: 10.1371/journal.pone.0269447
- Subjects: ANTIPROTOZOÁRIOS; LEISHMANIA; LEISHMANIOSE CUTÂNEA; DOENÇAS NEGLIGENCIADAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2022
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
QUEIROZ, Aline Cavalcanti de et al. Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity. Plos one, v. 17, n. 6, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0269447. Acesso em: 30 mar. 2026. -
APA
Queiroz, A. C. de, Barbosa, G., Oliveira, V. R. T. de, Alves, H. de M., Alves, M. A., Carregaro, V., et al. (2022). Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity. Plos one, 17( 6), 1-16. doi:10.1371/journal.pone.0269447 -
NLM
Queiroz AC de, Barbosa G, Oliveira VRT de, Alves H de M, Alves MA, Carregaro V, Silva JS da, Barreiro EJ, Alexandre-Moreira MS, Lima LM. Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity [Internet]. Plos one. 2022 ; 17( 6): 1-16.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1371/journal.pone.0269447 -
Vancouver
Queiroz AC de, Barbosa G, Oliveira VRT de, Alves H de M, Alves MA, Carregaro V, Silva JS da, Barreiro EJ, Alexandre-Moreira MS, Lima LM. Pre-clinical evaluation of LASSBio-1491: from in vitro pharmacokinetic study to in vivo leishmanicidal activity [Internet]. Plos one. 2022 ; 17( 6): 1-16.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1371/journal.pone.0269447 - CCR2 signaling contributes to the differentiation of protective inflammatory dendritic cells in Leishmania braziliensis infection
- Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection
- Interleukin-27 (IL-27) mediates susceptibility to visceral Leishmaniasis by suppressing the IL-17-neutrophil response
- T1/ST2 deficient mice display protection against Leishmania infantum experimental infection
- T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses
- Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced
- Inflammasome-derived IL-1'beta' production induces nitric oxide-mediated resistance to Leishmania
- Protective role of 5-lipoxigenase during Leishmania infantum infection is associated with TH17 subset
- Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection
- Association of IL-9, IL-10, and IL-17 cytokines with hepatic fibrosis in human Schistosoma mansoni infection
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
